Pfizer Inc. (PFE) Capital expenditures 2016–2025
Pfizer Inc. (PFE) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$2.6BFY2025 · since FY2016: $1.8B → $2.6B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $2.6B | -9.6% |
| FY2024 | $2.9B | -25.5% |
| FY2023 | $3.9B | +20.7% |
| FY2022 | $3.2B | +19.4% |
| FY2021 | $2.7B | +21.8% |
| FY2020 | $2.2B | +8.8% |
| FY2019 | $2.0B | +3.1% |
| FY2018 | $2.0B | +1.4% |
| FY2017 | $2.0B | +7.3% |
| FY2016 | $1.8B | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice